Extensive-stage Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Extensive-stage Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating BMS-986012 with carboplatin, etoposide, and nivolumab as first-line therapy for extensive-stage small cell…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC [Phase 2]
A Phase 2 clinical trial evaluates tislelizumab in combination with chemotherapy and thoracic radiotherapy for extensive-stage small-cell lu…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2 [Phase 2]
Phase 2 study evaluating Tarlatamab in pretreated extensive-stage small cell lung cancer with ECOG performance status 2 is currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy [Phase 2]
Phase 2 trial update reporting safety and early effectiveness signals for BNT327 in combination with chemotherapy for small-cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment [Phase 2]
Phase 2 study evaluating tarlatamab in Chinese participants with extensive-stage small cell lung cancer after two or more prior lines of the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer [Phase 2]
Phase 2 trial update reporting results for MGC018 in relapsed or refractory extensive-stage small-cell lung cancer; the study is not current…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer [Phase 2]
Phase 2 trial evaluating first-line anlotinib plus durvalumab with platinum-etoposide for extensive-stage small-cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer [Phase 2]
Phase 2 trial of Monalizumab in combination with durvalumab for small cell lung cancer is currently suspended.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer [Phase 1]
An ongoing Phase 1 clinical trial is evaluating valemetostat in combination with atezolizumab for extensive-stage small cell lung cancer. Th…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy [NA]
This completed clinical trial evaluated multidisciplinary-team-based nursing for patients with small cell lung cancer during chemo-immunothe…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer [Phase 3]
A Phase 3 study evaluating sacituzumab govitecan versus standard of care for previously treated extensive-stage small cell lung cancer is cu…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer [Phase 1]
This Phase 1 trial update reports results for pembrolizumab combined with concurrent chemoradiotherapy or radiation therapy in small cell lu…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC [Phase 2]
A Phase 2 clinical trial is evaluating the combination of lurbinectedin and durvalumab in participants with extensive-stage small-cell lung …
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) [Phase 1]
Phase 1 study evaluating first-line Tarlatamab combined with Carboplatin, Etoposide, and a PD-L1 inhibitor for extensive-stage small cell lu…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)
This clinical trial update indicates that the study evaluating the effectiveness and safety of Zepzelca (lurbinectedin) in adults with exten…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of the triple combination niraparib, temozolomide, and atezolizumab in patients with …
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER [Phase 1]
This entry announces a Phase I clinical trial of ALPS12 for extensive stage small cell lung cancer, which is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Sacituzumab Tirumotecan Plus Anlotinib in Previously Treated ES-SCLC [Phase 2]
A Phase 2 clinical trial is evaluating the combination of Sacituzumab Govitecan and Anlotinib in previously treated extensive-stage small ce…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy Progression [Phase 2]
This document reports a Phase 2 prospective, single-arm exploratory study evaluating the investigational drug IBI363 in patients with extens…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC [Phase 3]
Phase III study evaluating HLX10 in combination with chemotherapy for extensive-stage small cell lung cancer has completed and posted result…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide [Phase 2]
A Phase 2 trial evaluating atezolizumab with carboplatin and etoposide in extensive-stage small cell lung cancer patients with ECOG performa…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of hSTC810 with paclitaxel in relapsed or refractory extensive-stage small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan [Phase 4]
Phase 4 clinical trial comparing trilaciclib versus placebo in patients with extensive-stage small cell lung cancer receiving topotecan is c…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating surufatinib plus anti-PD-1/PD-L1 as maintenance therapy in extensive-stage small cell lung cancer has been…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) [Phase 2]
Phase 2 results evaluate pembrolizumab in combination with chemotherapy and investigational agents as first-line therapy for extensive-stage…